Amicus Therapeutics, Inc. (FOLD)

Amicus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,255	2,815	4,161	3,430	3,218	6,017
Market Cap Growth	-39.95%	-32.36%	21.31%	6.59%	-46.51%	142.44%
Enterprise Value	2,416	3,010	4,335	3,527	3,101	5,948
Last Close Price	7.19	9.42	14.19	12.21	11.55	23.09
Forward PE	41.63	87.63	-	-	-	-
PS Ratio	3.86	5.33	10.42	10.42	10.53	23.06
PB Ratio	10.84	14.51	25.98	27.88	10.47	21.01
P/TBV Ratio	-	-	-	-	29.37	67.93
EV/Sales Ratio	4.23	5.70	10.86	10.71	10.15	22.80
EV/EBITDA Ratio	73.33	70.63	-	-	-	-
EV/EBIT Ratio	96.46	88.35	-	-	-	-
Debt / Equity Ratio	2.17	2.29	2.78	3.67	1.43	1.54
Debt / EBITDA Ratio	10.95	8.61	-	-	-	-
Asset Turnover	0.73	0.68	0.53	0.40	0.34	0.30
Inventory Turnover	0.47	0.59	0.89	1.53	1.49	1.85
Quick Ratio	2.01	2.36	2.23	2.59	3.67	4.09
Current Ratio	3.21	3.39	2.88	3.05	4.09	4.47
Return on Equity (ROE)	-22.62%	-31.68%	-107.04%	-109.93%	-84.37%	-72.59%
Return on Assets (ROA)	2.00%	2.72%	-6.12%	-15.68%	-13.95%	-17.55%
Return on Capital (ROIC)	2.56%	3.43%	-7.78%	-19.32%	-16.93%	-21.55%
Return on Capital Employed (ROCE)	3.90%	5.40%	-	-	-	-
Earnings Yield	-1.73%	-1.99%	-3.64%	-6.90%	-7.78%	-4.60%
FCF Yield	-2.22%	-1.33%	-1.84%	-4.97%	-6.41%	-3.93%
Buyback Yield / Dilution	-1.96%	-3.12%	-2.11%	-6.50%	-4.85%	-7.67%

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q